Ensuring Biopharmaceutical Purity Through Rigorous Host Cell Protein Testing Protocols
In the production of recombinant proteins, the presence of residual host cell proteins remains a significant concern for manufacturers. These impurities can affect the stability and safety of the final therapeutic product. Advanced analytical techniques are required to detect and quantify these proteins to ensure compliance with stringent safety standards.
Mass spectrometry and enzyme-linked immunosorbent assays are the primary tools used to identify these complex protein mixtures. Developing sensitive and robust assays is essential for maintaining the integrity of bioprocessing workflows. Continuous monitoring throughout the purification steps helps in minimizing the risk of immunogenic reactions in patients receiving these treatments.
12 Views